Brief: Bioporto: Danish Team Of Researchers To Test Treatment Of Critically Ill Patients Suffering From COVID-19

BioPorto A/S

14/05/2020 15:53

May 14 (Reuters) - Bioporto A/S  BIOPOR.CO :
    * DANISH TEAM OF RESEARCHERS TO TEST TREATMENT OF CRITICALLY
ILL
PATIENTS SUFFERING FROM COVID-19
    * INNOVATION FUND DENMARK HAS AWARDED DKK 3 MILLION TO TEST
IF
DRUG ILOPROST CAN IMPROVE SURVIVAL RATES IN SARS-CO-V2 INFECTED
PATIENTS IN NEED OF RESPIRATORY TREATMENT
    * STUDY WILL BE CONDUCTED IN A PARTNERSHIP BETWEEN LEADING
HOSPITALS IN CAPITAL REGION OF DENMARK AND BIOPORTO A/S, A
DANISH DIAGNOSTICS COMPANY
    * INTENTION OF STUDY IS TO COMPARE EFFICACY OF ILOPROST TO
PLACEBO
IN A GROUP OF 80 PATIENTS

Source text for Eikon:  ID:nGNE3Gm06h 
Further company coverage:  BIOPOR.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))